Publications SOMA.LIV
-
Current publications
Symptomerleben und Coping-Strategien bei Patient*innen mit Primär Biliärer Cholangitis: eine qualitative Interviewstudie im Rahmen von SOMA.LIV
Hasenbank N, Buck L, Maehder K, Hartl J, Löwe B, Schramm C, Toussaint A.
Psychother Psychosom Med Psychol 2024; doi: 10.1055/a-2434-6837Understanding illness experiences of patients with primary sclerosing cholangitis: a qualitative analysis within the SOMA.LIV study.
Loesken C, Maehder K, Buck L, Hartl J, Löwe B, Schramm C,Toussaint A.
BMC GASTROENTEROL 23, 12 (2023). doi.10.1186/s12876-023-02645-2Factors associated with severity andpersistence of fatigue in patients withprimary biliary cholangitis: study protocolof a prospective cohort study with a mixed-methodsapproach (SOMA.LIV).
Toussaint A, Buck L, Hartl J, Löwe B, Schramm C.
BMJ OPEN 2022;12:e061419. doi:10.1136/bmjopen-2022-061419 -
Project-related publications
Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.
Löwe B, Levenson J, Depping M, Hüsing P, Kohlmann S, Lehmann M, Shedden-Mora M, Toussaint A, Uhlenbusch N, Weigel A. (2021)
PSYCHOL MED. 1-17. doi: 10.1017/S0033291721004177. Epub ahead of print.Persistence rate of DSM-5 somatic symptom disorder: 4-year follow-up in patients from a psychosomatic outpatient clinic.
Behm AC, Hüsing P, Löwe B, Toussaint A. (2021)
COMPR PSYCHIATRY.110:152265. doi: 10.1016/j.comppsych.2021.152265.
Epub 2021 Jul 19. PMID: 34311179.A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.
Liwinski T, Casar C, Ruehlemann MC, Bang C, Sebode M, Hohenester S, Denk G, Lieb W, Lohse AW, Franke A, Schramm C.
ALIMENT PHARMACOL THER. 2020;51(12):1417-28.Alterations of the bile microbiome in primary sclerosing cholangitis.
Liwinski T, Zenouzi R, John C, Ehlken H, Rühlemann MC, Bang C, Groth S, Lieb W, Kantowski M, Andersen N, Schachschal G, Karlsen TH, Hov JR, Rösch T, Lohse AW, Heeren J, Franke A, Schramm C.
GUT. 2020;69(4):665-72.Detecting DSM-5 somatic symptom disorder: criterion validity of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder – B Criteria Scale (SSD-12).
Toussaint A, Hüsing P, Kohlmann S, Löwe B.
PSYCHOL MED. 2020;50(2):324-33.Patients With Primary Biliary Cholangitis and Fatigue Present With Depressive Symptoms and Selected Cognitive Deficits, but With Normal Attention Performance and Brain Structure.
Zenouzi R, van der Gablentz J, Heldmann M, Göttlich M, Weiler-Normann C, Sebode M, Ehlken H, Hartl J, Fellbrich A, Siemonsen S, Schramm C, Münte TF, Lohse AW.
PLOS ONE. 2018;13(1):e0190005.Bile Acids, the Microbiome, Immunity, and Liver Tumors.
Schramm C.
NEW ENGL J MED. 2018;379(9):888-90.Comparing diagnostic concepts of ICD-10 somatoform disorders and DSM-5 somatic symptom disorders in patients from a psychosomatic outpatient clinic.
Hüsing P, Löwe B, Toussaint A.
J PSYCHSOM RES. 2018;113:74-80.Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder and functional somatic syndromes: EURONET-SOMA recommendations.
Rief W, Burton C, Frostholm L, Henningsen P,Kleinstäuber M, Kop WJ, Löwe B, Martin A, Malt U, Rosmalen J, Schröder A, Shedden-Mora M, Toussaint A, van der Feltz-Cornelis C, EURONET-SOMA Group.
PSYCHOSOM MED. 2017;79(9):1008-15.A European research network to improve diagnosis, treatment and care for patients with persistent somatic symptoms: work report of the EURONET-SOMA conference series.
Weigel A, Hüsing P, Kohlmann S, Lehmann M, Shedden Mora M, Toussaint A, Löwe B.
J PSYCHOSOM RES. 2017;97:136-8.Primary biliary `cirrhosis´: time to replace a misnomer.
Wahl I, Feige A, Löwe B, Weiler-Normann C, Rose MD, Lohse AW, Schramm C.
HEPATOLOGY. 2015;61(3):1091.Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis.
Schramm C, Wahl I, Weiler-Normann C, Voigt K, Wiegard C, Glaubke C, Brähler E, Löwe B, Lohse AW, Rose M.
J HEPATOL. 2014;60(3):618-24. -
Lectures
Krankheitserfahrungen von Patient:innen mit primär sklerosierender Cholangitis
- eine qualitative Analyse im Rahmen der SOMA.LIV Studie
Lösken C.
German Congress for Psychosomatic Medicine and Psychotherapy, 3.-5. May 2023, Berlin, Germany. [Lecure, 5. May 2023]Der Einfluss von Symptomerwartungen auf mentale Fatigue bei Patient:innen mit Primär Biliärer Cholangitis (SOMA.LIV)
Buck L.
German Congress for Psychosomatic Medicine and Psychotherapy, 3.-5. May 2023, Berlin, Germany. [Lecure, 4. May 2023]Symptomwahrnehmung bei Patient:innen mit Primär Biliärer Cholangitis (SOMA.LIV)
Hasenbank N.
German Congress for Psychosomatic Medicine and Psychotherapy, 3.-5. May 2023, Berlin, Germany. [Lecure, 4. May 2023]